Novel therapeutic cancer vaccine goes to human clinical trials

Medical researchers have launched a Phase I clinical trial of a therapeutic melanoma vaccine designed to reprogram a patient's immune system to destroy tumors. The vaccine consists of a small disk-like, biodegradable sponge that's infused with signaling molecules and components of the patient's tumor.

Read the whole article on Science Daily

More from Science Daily